XML 70 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Unaudited Condensed Consolidated Statements of Shareholders' Investment - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period $ 1,938,087,820 [1] $ 1,861,751,660
Issuance of common stock from stock plan transactions $ 7,355,488 10,514,554
Repurchases of common stock (in shares) (7,000,000.0)  
Repurchases of common stock $ (178,819,584) (96,267,228)
Stock-based compensation expense related to stock options, employee stock purchases and restricted stock 6,356,070 4,862,947
Dividends declared (29,383,859) (29,392,200)
Net Income 89,505,801 104,280,411
Other comprehensive loss 1,503,897 1,324,604
Balance at end of period $ 1,834,605,633 $ 1,857,074,748
Common Stock    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance (in shares) 251,277,515 259,328,613
Balance at beginning of period $ 15,076,651 $ 15,559,717
Issuance of common stock from stock plan transactions (in shares) 607,175 980,670
Issuance of common stock from stock plan transactions $ 36,431 $ 58,840
Repurchases of common stock (in shares) (7,019,032) (4,724,938)
Repurchases of common stock $ (421,143) $ (283,496)
Ending balance (in shares) 244,865,658 255,584,345
Balance at end of period $ 14,691,939 $ 15,335,061
Additional  Paid-In Capital    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period 807,928,139 745,324,144
Issuance of common stock from stock plan transactions 7,319,057 10,455,714
Repurchases of common stock (20,214,812) (12,001,344)
Stock-based compensation expense related to stock options, employee stock purchases and restricted stock 6,356,070 4,862,947
Balance at end of period 801,388,454 748,641,461
Retained  Earnings    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period 1,116,372,133 1,102,468,137
Repurchases of common stock (158,183,629) (83,982,388)
Dividends declared (29,383,859) (29,392,200)
Net Income 89,505,801 104,280,411
Balance at end of period 1,018,310,446 1,093,373,960
Accumulated  Other Comprehensive Income (Loss)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period (1,289,103) (1,600,338)
Other comprehensive loss 1,503,897 1,324,604
Balance at end of period $ 214,794 $ (275,734)
[1] The condensed consolidated balance sheet at December 31, 2019 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.